Shareholders Work to Make AIDS Drugs Available Worldwide
Abbott Labs changes its tune and lowers price of AIDS fighting drugs in low-and-middle income countries.

ICCR Benchmarks Pharma Responses to AIDS and Diseases of Poverty in Emerging Markets
The Interfaith Center on Corporate Responsibility report assesses 15 pharmaceutical companies, and finds all of them falling short of best practice in most areas on AIDS and neglected diseases.

White House and Interfaith Center on Corporate Responsibility Address Pediatric AIDS
Bush Administration launches a new public-private partnership on Pediatric AIDS, an area where ICCR engages pharmaceutical companies in shareowner advocacy.